FSS-621-II - Veracyte, Inc. - 36F79718D0524

DEPARTMENT OF VETERANS AFFAIRS

Federal Supply Schedule Service

Authorized Federal Supply Schedule Price List

On-line access to contract ordering information, terms and conditions, up-to-date pricing, and the option to create an electronic delivery order are available through GSA Advantage!, a menu- driven database system.

The INTERNET address GSA Advantage! is: www.GSAAdvantage.gov.

Medical Laboratory Testing and Analysis Services

FSC Group 621 Part II

FSC Class Q301

Contract Number: 36F79718D0524

Contract Period: August 1, 2018 to July 31, 2028

Incorporating: Option to Extend Contract P00007 effective Aug. 1, 2023

For more information on ordering from Federal Supply Schedules go to the GSA Schedules page at GSA.gov

Veracyte, Inc.

6000 Shoreline Court, Suite 100

South San Francisco, CA 94080

Phone: (650) 243-6300

Fax: (650) 243-6388 www.veracyte.com

Unique Entity ID (UEI) Number: JS7GBP6LCMN6 Central Contractor Registration (CCR) Cage Code: 60GJ7

Business size: Other than Small Business

“Prices Shown Herein are Net (discount deducted)” http://www.gsaadvantage.gov/ http://www.veracyte.com/

Customer Information

1a. Awarded Special Item Number(s):

621-200 Anatomic Pathology 621-205 Endocrinology

2. Maximum order: $100,00.00

3. Minimum order: 1 test

4. Geographic coverage (delivery area): 50 United States, District of Columbia and Puerto Rico

5. Point(s) of production (city, county, and state or foreign country):

Veracyte, Inc.

6000 Shoreline Court, Suite 100 South San Francisco, CA 94080

6. Discount from list prices or statement of net price:

Prices shown herein are Net (Discount Deducted)

7. Quantity discounts: None

8a. Prompt payment terms: 1% 20 days; Net 30 days

8b. Notification of Government purchase card acceptance: Government purchase card is accepted up to, at, and above the Micro Purchase Threshold (MTP)

9. Foreign Items (list items by country of origin): Not applicable

10a. Time of Delivery: 14 days ARO

10b. Expedited Delivery: None

10c. Overnight and 2-day delivery: None

10d. Urgent Requirements: None

11a. Testing/specimen pick up/request procedures:

• The physician facility will notify Veracyte the desire to order the Afirma test.

Veracyte will create the client account with the Client Services group to arrange for shipment of the kit, which provides all the material, instructions, and forms to order the Afirma test. The facility may contact Veracyte’s Client Services team at 888.923.4762 or email afirmainfo@veracyte.com.

• The physician’s office will follow the instructions provided in the kit on collection of the specimen sample, packaging of the sample and shipping instructions. Veracyte uses FedEx as the shipping service for Afirma kits.

11b. Specimen Collection and Handling Requirements (Price list must indicate whether patient demographic information is available upon request in either hardcopy or electronic format, listing any e-mail addresses or web links necessary to obtain the Requirements): FNA specimens from patient thyroid nodules are collected by a physician and placed immediately into an RNA preservative solution that is shipped to Veracyte’s CLIA Laboratory.

mailto:afirmainfo@veracyte.com

11c. Hours of Operation, as proposed by the contractor in Document 02 - Vendor Response Document and agreed upon by the contract award (this should detail the hours of operation upon which the turnaround times are based):

Tuesday through Saturday, 8:00 am to 5:00 pm, Pacific Time

11d. Turnaround Time (TAT) Table, as proposed by the contractor in Document 02 - Vendor

Response Document and agreed upon by the contract award (in lieu of #11 in I-FSS-600):

TAT Max is 25 days

11e. Test Results Delivery: Reports are provided to ordering physicians electronically, via fax, or by mail according to client preference.

12a. Ordering address(es):

Veracyte, Inc.

6000 Shoreline Court, Suite 300 South San Francisco, CA 94080

12b. Ordering procedures:

Veracyte provides a sample collection kit through their Customer Care department (888-9-AFIRMA, support@veracyte.com). The kit will provide the customer with all necessary shipping labels, test requisition forms, instructions, and supplies required to collect patient samples. The boxes are shipped Priority Overnight.

13. Payment address:

Veracyte, Inc.

PO Box 39000 San Francisco, CA 94139

14. Export packing charges: Not applicable

15. Terms and conditions of any other services (if applicable): Not Applicable

16. List of participating dealers (if applicable): Not Applicable

17. If applicable, indicate that Section 508 compliance information is available on Electronic and

Information Technology (EIT) supplies and services and show where full details can be found (e.g., contractor’s website or other location). The EIT standards can be found at www.Section508.gov/: Not Applicable

18. Data Universal Number System (DUNS) number: 018208647

19. Notification regarding registration in System for Award Management (SAM) database: Yes, registered

20. Use of Subcontractors (i.e. Test Send Outs): Not Applicable

21. LOINC Code(s): Not Applicable http://www.section508.gov/

Contractor: Veracyte, Inc.

Contract Number: 36F79718D0524

Contract Period: August 1, 2018 to July 31, 2028 Prices Effective: 10/1/2022

FSS Price List

SIN# TEST

ORDER

CODE

TEST NAME AND DESCRIPTION CPT

CODE

UOI FSS PRICE

w/IFF ($)

621-205 CPT 81546 1. Test Name: Afirma Genomic Sequencing Classifier (GSC)

2. Description: Among patients with thyroid nodules whose fine needle aspiration (FNA) cytopathology is indeterminate, Afirma identifies patients with benign nodules that can safely avoid surgery and informs the extent of surgery when nodules are suspicious.

3. Assay Method: RNA whole-transcriptome sequencing derives the prediction behavior of proprietary algorithms to provide a risk of malignancy assessment, prognostic information, and identifies molecular alterations with corresponding FDA approved targeted therapies.

4. CPT Code: 81546

81546 EA $3,232.00

621-200 Envisia GC 1. Test Name: Envisia Genomic Classifier

2. Description: Differentiate IPF from other interstitial lung diseases (ILD) without the need for invasive, risky and costly surgery.

3. Assay Method: Next Generation Sequencing (NGS). Genomic sequencing data is analyzed by the Veracyte RNA sequencing pipeline to generate an Envisia Genomic Classifier score.

4. CPT Code: 81554

81554 EA $5,575.76

621-200 Percepta GSC 1. Test Name: Percepta Genomic Sequencing Classifier

2. Description: Stratifies the risk of primary lung cancer to guide patient management when bronchoscopy results are inconclusive.

3. Assay Method: Next Generation Sequencing (NGS). Genomic sequencing data is analyzed by the Veracyte RNA sequencing pipeline to generate a Percepta Genomic Classifier score.

4. CPT Code: 81479

81479 EA $2,585.86